Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02941393
Other study ID # R12229
Secondary ID
Status Completed
Phase N/A
First received September 7, 2016
Last updated March 19, 2018
Start date November 2012
Est. completion date December 31, 2017

Study information

Verified date March 2018
Source Tampere University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this study, parturients will be randomized to either internal or external tocodynamometry contractions' follow up. Investigators recruit primiparous, those who try to have vaginal birth after cesarean section and multiparous, who need oxytocin during labor. Primary endpoint is the number of operative labors in each group. Secondary endpoints are the duration of labor, the use of oxytocin and the condition of the newborn.


Recruitment information / eligibility

Status Completed
Enrollment 1500
Est. completion date December 31, 2017
Est. primary completion date December 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria:

- gestational age = 37 weeks

- singleton pregnancy

- a fetus in cephalic position

- normal cardiotocograph in the time of randomization

- cervical ripening < 7 cm

- either 1) primipara, 2) multipara, who needs oxytocin during first stage of labor or 3) parturients with previous cesarean section

Exclusion Criteria:

- parturient with hepatitis or HIV or other significant viral infection

- Acute infections (fever over 37,5, or C-reactive protein over 20) in the time of randomization

- Estimated fetal weight over 4,5 kg

- Suspected fetal abnormality

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Intrauterine pressure catheter

External tocodynamometry


Locations

Country Name City State
Finland Cetral Finland Central Hospital Jyväskylä Central Finland
Finland Tampere University Hospital Tampere Pirkanmaa

Sponsors (2)

Lead Sponsor Collaborator
Tampere University Hospital Central Finland Hospital District

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of cesarean sections through study completion, an average of 6 years
Primary Number of operative vaginal deliveries through study completion, an average of 6 years
Secondary Duration of labor From time of first regular contraction to birth
Secondary Newborn admission to the pediatric care unit 3 days after birth
Secondary The use of Oxytocin during labor From beginning of the use of oxytocin to the birth
Secondary Apgar scores 10 min after birth
Secondary Ph of umbilical artery immediately after birth
See also
  Status Clinical Trial Phase
Completed NCT02487797 - Comparison of Low-dose and High-dose Oxytocin Regimens for Labor Augmentation Phase 4
Terminated NCT02741141 - A Comparative Study of the Effect of Two Partographs on the Cesarean Section Rate in Women in Spontaneous Labour N/A
Terminated NCT00279071 - Use of Acupuncture for Stimulation of Labour Phase 2
Not yet recruiting NCT02934516 - Push With Lower Uterine Segment Support N/A
Not yet recruiting NCT01530113 - Childhood Sexual Abuse, Vaginismus and Labor Dystocia N/A
Active, not recruiting NCT02643108 - Lateral Episiotomy or Not in Vacuum Assisted Delivery in Non-parous Women N/A
Active, not recruiting NCT02486822 - Labor Scale Versus WHO Partograph in the Management of Labor N/A
Completed NCT04649593 - The Study of Giving Birth, a Study About Treatment of Labor Dystocia N/A
Completed NCT01291355 - Maternal Positioning and Occipitoposterior Fetal Position N/A
Not yet recruiting NCT05341076 - Labor Scale Versus WHO Partograph for Management of Labor (ScaLP) N/A
Terminated NCT01107158 - LXRs, Cholesterol Metabolism and Uterine Dystocia N/A